Envoy Medical, Inc. (COCH) Form 8-K — Jun 25, 2026
Envoy Medical's Compensation Committee approved changes to CEO Brent Lucas's compensation package, increasing his base salary to $420,000 and establishing a $105,000 target bonus tied to strategic performance goals for 2026 and 2027. The Company also granted Mr. Lucas 1,000,000 stock options exercisable at $0.634 per share and 1,000,000 restricted stock units (RSUs). The stock options will vest over four years, while the RSUs are contingent upon U.S.
Key figures
- Rsus granted
- 1000000
- Ceo base salary
- $420,000
- Options granted
- 1000000
- Ceo target bonus
- $105,000
- Rsu vesting trigger
- FDA approval of Acclaim cochlear implant
- Option exercise price
- $0.634
- Option vesting period
- 4 years
Price after filing
1 day: 0.0%7 days: +11.8%30 days: -1.8%
Close on the filing date to close N calendar days later (from $0.67). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.